You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over

  • Technology appraisal guidance
  • Reference number: TA956
  • Published:  11 March 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

11429-Etrasimod-for-Ulcerative-Colitis-V1.0-FEB2022-NON-CONF.pdf (nihr.ac.uk)

This page was last updated: 29 March 2022

Back to top